Literature DB >> 23059781

Reasonable extent of lymph node dissection in intentional segmentectomy for small-sized peripheral non-small-cell lung cancer: from the clinicopathological findings of patients who underwent lobectomy with systematic lymph node dissection.

Yuki Matsumura1, Tomoyuki Hishida, Junji Yoshida, Keiju Aokage, Genichiro Ishii, Kanji Nagai.   

Abstract

INTRODUCTION: Currently, randomized clinical trials to evaluate segmentectomy compared with lobectomy for peripheral cT1aN0M0 non-small-cell lung cancer (NSCLC) are ongoing. During segmentectomy, some lobar-segmental lymph nodes (LSNs) can be difficult to resect for anatomical reasons. The purpose of this study was to clarify the reasonable extent of dissection during intentional segmentectomy for peripheral cT1aN0M0 NSCLC.
METHODS: We reviewed the records of patients who underwent lobectomies and systematic lymph node dissections for cT1aN0M0 NSCLC from 1992 to 2009. Among them, a total of 307 patients whose primary nodule was located in the outer third peripheral lung field on thin-section computed tomography (TSCT), and who could be candidates for intentional segmentectomy were enrolled in this study. We analyzed the clinical and radiological factors, which may predict nodal metastasis, and the distribution patterns of lymph node metastases. In particular, we set out to evaluate the specific LSNs, which are difficult to resect on segmentectomy (isolated LSNs [iLSNs]).
RESULTS: Of all patients, 34 (11%) had lymph node metastases (pN1: 9, pN2: 25). The median tumor sizes and tumor disappearance rates (TDRs) on TSCT were significantly larger and lower, respectively, compared with those of the remaining 273 node-negative patients. All 34 node-positive patients had a solid-dominant component on TSCT (TDR < 0.25). Of these, nine patients (n = 5, station 11, n = 4, station 13) were iLSN positive, but all of them also had metastases to station 12 or mediastinal lymph nodes. No patients had solitary metastasis in iLSNs.
CONCLUSIONS: The reasonable extent of dissection for intentional segmentectomy for small (≤ 2 cm) peripheral NSCLC includes LSNs in the segments with tumors, and the hilar and mediastinal nodes. It may not be necessary to examine iLSNs. Systematic lymph node dissection might not be necessary for tumors with ground grass opacity on TSCT (TDR ≥ 0.25).

Entities:  

Mesh:

Year:  2012        PMID: 23059781     DOI: 10.1097/JTO.0b013e31826912b4

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  9 in total

1.  Unless I see, I will not believe.

Authors:  Pietro Bertoglio; Stéphane Renaud; Francesco Guerrera
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

2.  Non-adjacent interlobar lymph node metastasis distant from small-sized peripheral non-small cell lung cancer.

Authors:  Tomohiro Maniwa; Toru Kimura; Masayuki Ohue; Yasushi Shintani; Jiro Okami
Journal:  Surg Today       Date:  2022-04-30       Impact factor: 2.549

3.  Clinical outcomes and changes in lung function after segmentectomy versus lobectomy for lung cancer cases.

Authors:  Bo Deng; Stephen D Cassivi; Mariza de Andrade; Francis C Nichols; Victor F Trastek; Yi Wang; Jason A Wampfler; Shawn M Stoddard; Dennis A Wigle; Robert K Shen; Mark S Allen; Claude Deschamps; Ping Yang
Journal:  J Thorac Cardiovasc Surg       Date:  2014-03-20       Impact factor: 5.209

4.  Log odds of positive lymph nodes are superior to other measures for evaluating the prognosis of non-small cell lung cancer.

Authors:  Peng Lv; Gang Chen; Peng Zhang
Journal:  Thorac Cancer       Date:  2014-10-23       Impact factor: 3.500

5.  Restrictive ventilatory impairment is associated with poor outcome in patients with cT1aN0M0 peripheral squamous cell carcinoma of the lung.

Authors:  Hiroyuki Tao; Junichi Soh; Hiromasa Yamamoto; Toshiya Fujiwara; Tsuyoshi Ueno; Makio Hayama; Mikio Okazaki; Ryujiro Sugimoto; Motohiro Yamashita; Yoshifumi Sano; Kazunori Okabe; Motoki Matsuura; Kazuhiko Kataoka; Shigeharu Moriyama; Shinichi Toyooka; Shinichiro Miyoshi
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

6.  Long-term outcomes of stage I NSCLC (≤3 cm) patients following segmentectomy are equivalent to lobectomy under analogous extent of lymph node removal: a PSM based analysis.

Authors:  Xiao Qu; Kai Wang; Tiehong Zhang; Hongchang Shen; Wei Dong; Qi Liu; Jiajun Du
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

7.  Meta-analysis of segmentectomy versus lobectomy for radiologically pure solid or solid-dominant stage IA non-small cell lung cancer.

Authors:  Sunyin Rao; Lianhua Ye; Li Min; Guangqiang Zhao; Ya Chen; Yunchao Huang; Jichen Yang; Shouyong Xiao; Run Cao
Journal:  J Cardiothorac Surg       Date:  2019-11-13       Impact factor: 1.637

8.  Analysis of Segmental Lymph Node Metastasis and Clinical Features in cT1N0M0 Lung Adenocarcinoma.

Authors:  Guanghao Sun; Yanbin Sun; Zifang Zou; Shun Xu
Journal:  Biomed Res Int       Date:  2020-02-18       Impact factor: 3.411

Review 9.  [Progress in Survival Prognosis of Segmentectomy for 
Early-stage Non-small Cell Lung Cancer].

Authors:  Sunyin Rao; Lianhua Ye; Xin Cui; Qinling Sun; Run Cao; Shouyong Xiao; Jichen Yang; Wei Wang; Guangqiang Zhao; Yunchao Huang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-09-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.